Gapping down
In reaction to disappointing earnings/guidance:
- UAA -17.2%, NLS -12.3%, SANM -8.5%, LL -8%, LODE -7.3%, OHI -6.4%, MAC -6.4%, AGCO -6.1%, NR -5.9%, CMP -5.7%, TYPE -5.7%, IIVI -4.7%, CHGG -3.6%, NVIV -3.4%, ADM -3.3%, ELVT -2.4%, AEIS -2%, IDXX -1.5%, CACC -1.4%, EIGI -1.2%, CG -0.9%
M&A news:
- BAK -1.8% (says was not approached by LyondellBasell (LYB) with any proposal for acquisition)
Other news:
- VYGR -9.8% ( announces an update to its VY-AADC program for advanced Parkinson's diseasel; Sanofi (SNY) 'has decided not to exercise its rights ')
- KOS -3.4% (completed drilling Hippocampe-1 exploration well; reservoirs were encountered in both exploration targets but these proved to be water bearing)
- OFC -2.6% (prices 8 mln shares of common stock at $31.00 per share)
- NKE -1.8% (in sympathy with UAA)
- LULU -1.6% (in sympathy with UAA)
- TRU -0.7% (announces secondary offering of 7,535,107 shares of common stock by stockholders)
Analyst comments:
- ERJ -1.6% (downgraded to Neutral from Overweight at JP Morgan)
- TRU -0.7% (prices 7,535,107 common stock offering by selling stockholders at $52.35/share)
